Medulloblastoma: WHO 2021 and Beyond.
Cotter JA, Hawkins C.
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):23-33. doi: 10.1177/10935266211018931.
[Medulloblastoma. Pathology].
Siegfried A, Delisle MB.
Neurochirurgie. 2021 Feb;67(1):28-38. doi: 10.1016/j.neuchi.2017.12.006. Epub 2018 Aug 14.
Understanding medulloblastoma.
Quinlan A, Rizzolo D.
JAAPA. 2017 Oct;30(10):30-36. doi: 10.1097/01.JAA.0000524717.71084.50.
Primary leptomeningeal medulloblastoma: a case-based review.
Russo C, Scala MR, Spennato P, Nastro A, Errico ME, De Martino L, Cinalli G.
Childs Nerv Syst. 2022 Mar;38(3):527-536. doi: 10.1007/s00381-021-05435-x. Epub 2022 Jan 21.
Medulloblastoma.
[No authors listed]
Nat Rev Dis Primers. 2019 Feb 14;5(1):12. doi: 10.1038/s41572-019-0067-2.
[Medulloblastoma].
Yamaguchi S, Fujimura M.
No Shinkei Geka. 2023 Sep;51(5):858-866. doi: 10.11477/mf.1436204827.
Management of high-risk medulloblastoma.
Bouffet E.
Neurochirurgie. 2021 Feb;67(1):61-68. doi: 10.1016/j.neuchi.2019.05.007. Epub 2019 Jun 20.
Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC, Mahoney EL, Pomeroy SL.
Neurotherapeutics. 2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y.
Targeting the medulloblastoma: a molecular-based approach.
Luzzi S, Giotta Lucifero A, Brambilla I, Semeria Mantelli S, Mosconi M, Foiadelli T, Savasta S.
Acta Biomed. 2020 Jun 30;91(7-S):79-100. doi: 10.23750/abm.v91i7-S.9958.
Medulloblastoma: Clinical presentation.
Vinchon M, Leblond P.
Neurochirurgie. 2021 Feb;67(1):23-27. doi: 10.1016/j.neuchi.2019.04.006. Epub 2019 Sep 5.
